Recruiting
Phase 2

Venetoclax, Isatuximab, Dexamethasone

Sponsor:

Oncotherapeutics

Code:

NCT06115135

Conditions

Multiple Myeloma in Relapse

Multiple Myeloma, Refractory

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Venetoclax

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-01. This information was provided to ClinicalTrials.gov by Oncotherapeutics on 2025-01-16.